These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31075397)

  • 1. Can Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predict Chimeric Antigen Receptor T Cell Adverse Effects?
    Wang J; Galal A
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):e187-e188. PubMed ID: 31075397
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic value of FDG-PET/CT response for patient selection before chimeric antigen receptor-T-cells therapy in non-Hodgkin lymphoma.
    Bailly C; Carlier T; Tessoulin B; Gastinne T; Kraeber-Bodere F; Le Gouill S; Bodet-Milin C
    Hematol Oncol; 2022 Oct; 40(4):796-800. PubMed ID: 35044695
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Adverse Effects of Chimeric Antigen Receptor T Cell Therapy in Patients with Non-Hodgkin Lymphoma.
    Wang J; Hu Y; Yang S; Wei G; Zhao X; Wu W; Zhang Y; Zhang Y; Chen D; Wu Z; Xiao L; Chang AH; Huang H; Zhao K
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1092-1098. PubMed ID: 30769193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response assessment in lymphoma: time to lower the bar?
    Elstrom RL
    Leuk Lymphoma; 2013 Apr; 54(4):673-4. PubMed ID: 22950372
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of various criteria in interpreting end of therapy F-18 labeled fluorodeoxyglucose positron emission tomography/computed tomography in patients with aggressive non-Hodgkin lymphoma.
    Manohar K; Mittal BR; Raja S; Bhattacharya A; Malhotra P; Varma S
    Leuk Lymphoma; 2013 Apr; 54(4):714-9. PubMed ID: 22870929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal cord involvement secondary to non-Hodgkin's lymphoma identified by ¹⁸F-FDG PET/CT.
    Mapelli P; Vanoli EG; Picchio M; Gianolli L
    Rev Esp Med Nucl Imagen Mol; 2013 Mar; 32(2):125. PubMed ID: 23246137
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoimmune lymphoproliferative syndrome and non-Hodgkin lymphoma: what 18F-fluorodeoxyglucose positron emission tomography/computed tomography can do in the management of these patients? Suggestions from a case report.
    Cistaro A; Pazè F; Durando S; Cogoni M; Faletti R; Vesco S; Vallero S; Quartuccio N; Treglia G; Ramenghi U
    Rev Esp Med Nucl Imagen Mol; 2014; 33(2):99-102. PubMed ID: 23845452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies.
    Terezakis SA; Hunt MA; Kowalski A; McCann P; Schmidtlein CR; Reiner A; Gönen M; Kirov AS; Gonzales AM; Schöder H; Yahalom J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):615-22. PubMed ID: 20933343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of positron emission tomography in diagnosing subcutaneous panniculitis-like T-cell lymphoma.
    Bennani-Baiti B; Yadav S; Flynt L; Bennani-Baiti N
    J Clin Oncol; 2015 Apr; 33(10):1216-7. PubMed ID: 25691676
    [No Abstract]   [Full Text] [Related]  

  • 11. Peritoneal lymphomatosis found on 18F-FDG PET/CT.
    van Rheenen RW; Bongaerts AH; Glaudemans AW
    Eur J Haematol; 2012 Dec; 89(6):503-4. PubMed ID: 22712752
    [No Abstract]   [Full Text] [Related]  

  • 12. Giant cardiac tumour thrombus on staging contrast enhanced ¹⁸F-FDG PET/CT in a case of non-Hodgkin's lymphoma.
    Jeph S; Thakur K; Shamim SA; Verma K; Aggarwal B; Aggarwal A
    Rev Esp Med Nucl Imagen Mol; 2014; 33(5):328-9. PubMed ID: 24618093
    [No Abstract]   [Full Text] [Related]  

  • 13. Diffuse skeletal muscles uptake of [18F] fluorodeoxyglucose on positron emission tomography in primary muscle peripheral T-cell lymphoma.
    Tanaka Y; Hayashi Y; Kato J; Yamada M; Koumura A; Sakurai T; Kimura A; Hozumi I; Hatano Y; Hirose Y; Takami T; Nakamura H; Kasahara S; Tsurumi H; Moriwaki H; Inuzuka T
    Intern Med; 2011; 50(18):2021-4. PubMed ID: 21921389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric Antigen Receptor T-Cell Therapy-Associated Cardiomyopathy in Patients With Refractory or Relapsed Non-Hodgkin Lymphoma.
    Ganatra S; Redd R; Hayek SS; Parikh R; Azam T; Yanik GA; Spendley L; Nikiforow S; Jacobson C; Nohria A
    Circulation; 2020 Oct; 142(17):1687-1690. PubMed ID: 33104402
    [No Abstract]   [Full Text] [Related]  

  • 15. Using positron emission tomography to assess tumor proliferation in non-Hodgkin lymphoma.
    Hofman MS; Hicks RJ
    Leuk Lymphoma; 2010 Feb; 51(2):183-5. PubMed ID: 20038239
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurolymphomatosis on 18F-FDG PET/CT: Diagnosis and Therapy Response.
    Gykiere P; Jans L; Degrieck B; Goethals I
    Clin Nucl Med; 2016 Feb; 41(2):142-3. PubMed ID: 26402124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DIAGNOSTIC ROLE OF FLUORINE-18 (18F) FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY IN DETECTING RECURRENT DISEASE IN PATIENTS WITH COLORECTAL CANCER AND ELEVATED CARCINOEMBRYONIC ANTIGEN.
    Matovina E; Mihailović J; Nikoletić K; Srbovan D
    Med Pregl; 2015; 68(11-12):376-81. PubMed ID: 26939303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan versus diagnostic contrast computed tomography in initial staging of pediatric patients with lymphoma.
    Cheng G; Servaes S; Zhuang H
    Leuk Lymphoma; 2013 Apr; 54(4):737-42. PubMed ID: 22957898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominal aortic aneurysm with bony erosion mimicking recurrent non-Hodgkin lymphoma on FDG PET/CT.
    Kim DW; Kim WH; Kim CG
    Clin Nucl Med; 2013 May; 38(5):e233-5. PubMed ID: 23143046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interim response assessment for Hodgkin lymphoma: size matters.
    Elstrom RL
    Leuk Lymphoma; 2012 Nov; 53(11):2095-6. PubMed ID: 22680772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.